BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 25014129)

  • 1. Population-based cost-offset estimation for the treatment of borderline personality disorder: projected costs in a currently running, ideal health system.
    Wunsch EM; Kliem S; Kröger C
    Behav Res Ther; 2014 Sep; 60():1-7. PubMed ID: 25014129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Societal cost-of-illness in patients with borderline personality disorder one year before, during and after dialectical behavior therapy in routine outpatient care.
    Wagner T; Fydrich T; Stiglmayr C; Marschall P; Salize HJ; Renneberg B; Fleßa S; Roepke S
    Behav Res Ther; 2014 Oct; 61():12-22. PubMed ID: 25113523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Population-based cost-offset analyses for disorder-specific treatment of anorexia nervosa and bulimia nervosa in Germany.
    Bode K; Götz von Olenhusen NM; Wunsch EM; Kliem S; Kröger C
    Int J Eat Disord; 2017 Mar; 50(3):239-249. PubMed ID: 28152200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness and Budget Impact of Specialized Psychotherapy for Borderline Personality Disorder: A Synthesis of the Evidence.
    Wetzelaer P; Lokkerbo J; Arntz A; van Aselt T; Smit F; Evers S
    J Ment Health Policy Econ; 2017 Dec; 20(4):177-190. PubMed ID: 29300704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Health care costs of borderline personality disorder and matched controls with major depressive disorder: a comparative study based on anonymized claims data.
    Bode K; Vogel R; Walker J; Kröger C
    Eur J Health Econ; 2017 Dec; 18(9):1125-1135. PubMed ID: 27990594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost of borderline personality disorder in Catalonia (Spain).
    Salvador-Carulla L; Bendeck M; Ferrer M; Andión O; Aragonès E; Casas M;
    Eur Psychiatry; 2014 Oct; 29(8):490-7. PubMed ID: 25174269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The cost of borderline personality disorder: societal cost of illness in BPD-patients.
    van Asselt AD; Dirksen CD; Arntz A; Severens JL
    Eur Psychiatry; 2007 Sep; 22(6):354-61. PubMed ID: 17544636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The value of psychological treatment for borderline personality disorder: Systematic review and cost offset analysis of economic evaluations.
    Meuldijk D; McCarthy A; Bourke ME; Grenyer BF
    PLoS One; 2017; 12(3):e0171592. PubMed ID: 28249032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dialectical behaviour therapy (DBT) in the treatment of borderline personality disorder.
    O'Connell B; Dowling M
    J Psychiatr Ment Health Nurs; 2014 Aug; 21(6):518-25. PubMed ID: 24191948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The burden of disease in patients eligible for mentalization-based treatment (MBT): quality of life and costs.
    Laurenssen EM; Eeren HV; Kikkert MJ; Peen J; Westra D; Dekker JJ; Busschbach JJ
    Health Qual Life Outcomes; 2016 Oct; 14(1):145. PubMed ID: 27733207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dialectical behavior therapy for borderline personality disorder: a meta-analysis using mixed-effects modeling.
    Kliem S; Kröger C; Kosfelder J
    J Consult Clin Psychol; 2010 Dec; 78(6):936-51. PubMed ID: 21114345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Promising therapy of borderline personality disorder].
    Andersson G
    Lakartidningen; 2006 Oct 18-24; 103(42):3188-90. PubMed ID: 17111989
    [No Abstract]   [Full Text] [Related]  

  • 13. Dialectical behaviour therapy skills training compared to standard group therapy in borderline personality disorder: a 3-month randomised controlled clinical trial.
    Soler J; Pascual JC; Tiana T; Cebrià A; Barrachina J; Campins MJ; Gich I; Alvarez E; Pérez V
    Behav Res Ther; 2009 May; 47(5):353-8. PubMed ID: 19246029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Health service utilization costs for borderline personality disorder patients treated with psychoanalytically oriented partial hospitalization versus general psychiatric care.
    Bateman A; Fonagy P
    Am J Psychiatry; 2003 Jan; 160(1):169-71. PubMed ID: 12505818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treating co-occurring Axis I disorders in recurrently suicidal women with borderline personality disorder: a 2-year randomized trial of dialectical behavior therapy versus community treatment by experts.
    Harned MS; Chapman AL; Dexter-Mazza ET; Murray A; Comtois KA; Linehan MM
    J Consult Clin Psychol; 2008 Dec; 76(6):1068-75. PubMed ID: 19045974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Difficulties in calculating productivity costs: work disability associated with borderline personality disorder.
    van Asselt AD; Dirksen CD; Arntz A; Severens JL
    Value Health; 2008; 11(4):637-44. PubMed ID: 18179672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dialectical behaviour therapy for post-traumatic stress disorder after childhood sexual abuse in patients with and without borderline personality disorder: a randomised controlled trial.
    Bohus M; Dyer AS; Priebe K; Krüger A; Kleindienst N; Schmahl C; Niedtfeld I; Steil R
    Psychother Psychosom; 2013; 82(4):221-33. PubMed ID: 23712109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A cost-effectiveness analysis of dialectical behaviour therapy for treating individuals with borderline personality disorder in the community.
    Murphy A; Bourke J; Flynn D; Kells M; Joyce M
    Ir J Med Sci; 2020 May; 189(2):415-423. PubMed ID: 31482522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness of dialectical behaviour therapy for borderline personality disorder in an inpatient setting.
    Kröger C; Schweiger U; Sipos V; Arnold R; Kahl KG; Schunert T; Rudolf S; Reinecker H
    Behav Res Ther; 2006 Aug; 44(8):1211-7. PubMed ID: 16226222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psychotherapy with borderline patients: II. A preliminary cost benefit study.
    Stevenson J; Meares R
    Aust N Z J Psychiatry; 1999 Aug; 33(4):473-7; discussion 478-81. PubMed ID: 10483841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.